After finishing her Masters degree Sandra Kummer worked in the fields of regenerative medicine an DNA damage and repair before joining the Zenz group in January 2020 as a research technician. In the Zenz group she is responsible for the organization and management of the lab. Furthermore, she is involved in drug screening and proteomic studies of different subtypes of leukemias and lymphomas.